Free Trial

Chimerix (CMRX) News Today

$0.89
0.00 (0.00%)
(As of 07/26/2024 ET)
Chimerix logo with Medical background
Chimerix (NASDAQ:CMRX) Stock Crosses Below 200 Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Stock Price Crosses Below 200-Day Moving Average of $0.99
Chimerix logo with Medical background
Chimerix (NASDAQ:CMRX) Shares Pass Below 200-Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Stock Crosses Below 200 Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Stock Price Passes Below Two Hundred Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Share Price Crosses Below Two Hundred Day Moving Average of $0.99
Vestal Point Capital LP Invests $1.35 Million in Chimerix, Inc. (NASDAQ:CMRX)
Vestal Point Capital LP bought a new stake in Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 1,400,000 shares of the biopharmaceutical company's stock, valued at approxima
Chimerix (NASDAQ:CMRX) Lifted to Hold at StockNews.com
StockNews.com raised Chimerix from a "sell" rating to a "hold" rating in a research report on Saturday.
Chimerix, Inc. (NASDAQ:CMRX) Short Interest Down 5.9% in May
Chimerix, Inc. (NASDAQ:CMRX - Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 1,280,000 shares, a drop of 5.9% from the April 30th total of 1,360,000 shares. Based on an average trading volume of 338,000 shares, the short-interest ratio is currently 3.8 days. Approximately 1.6% of the company's shares are sold short.
Chimerix (NASDAQ:CMRX) Rating Increased to Hold at StockNews.com
StockNews.com upgraded shares of Chimerix from a "sell" rating to a "hold" rating in a research report on Wednesday.
Chimerix Inc.
Chimerix (NASDAQ:CMRX) Downgraded by StockNews.com to "Sell"
StockNews.com cut Chimerix from a "hold" rating to a "sell" rating in a report on Friday.
Brokers Offer Predictions for Chimerix, Inc.'s FY2028 Earnings (NASDAQ:CMRX)
Chimerix, Inc. (NASDAQ:CMRX - Free Report) - Equities research analysts at Capital One Financial reduced their FY2028 earnings per share estimates for shares of Chimerix in a research report issued on Wednesday, May 1st. Capital One Financial analyst N. Quibria now anticipates that the biopharmac
Chimerix (NASDAQ:CMRX) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS
Chimerix (NASDAQ:CMRX - Get Free Report) issued its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.04). Chimerix had a negative net margin of 25,337.96% and a negative return on equity of 37.93%. During the same quarter in the previous year, the firm posted ($0.24) EPS.
Q1 2024 Chimerix Inc Earnings Call
Chimerix GAAP EPS of -$0.25
Chimerix: Q1 Earnings Snapshot
What Wall Street expects from Chimerix's earnings
Chimerix (CMRX) Set to Announce Quarterly Earnings on Wednesday
Chimerix (NASDAQ:CMRX) will be releasing earnings before the market opens on Wednesday, May 1, Zacks reports.
CMRX Apr 2024 1.000 put
CMRX Apr 2024 2.000 call
Chimerix (NASDAQ:CMRX) Earns "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $11.00 price target on shares of Chimerix in a report on Friday.
Preview: Chimerix's Earnings
Chimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99
Chimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99
Chimerix Appoints Lisa Decker to Board of Directors
Positive Signs As Multiple Insiders Buy Chimerix Stock
Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.

We’re in a code red crisis and 99% of Americans are clueless (Ad)

Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES!

And how YOU can prepare for the next 2024 BOOM here! 

CMRX Media Mentions By Week

CMRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMRX
News Sentiment

1.10

0.62

Average
Medical
News Sentiment

CMRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMRX Articles
This Week

2

1

CMRX Articles
Average Week

Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMRX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners